title: Response of human REV1 to different DNA damage: preferential dCMP insertion opposite the lesion.
abstract: REV1 functions in the DNA polymerase zeta mutagenesis pathway. To help understand the role of REV1 in lesion bypass, we have examined activities of purified human REV1 opposite various template bases and several different DNA lesions. Lacking a 3'-->5' proofreading exonuclease activity, purified human REV1 exhibited a DNA polymerase activity on a repeating template G sequence, but catalyzed nucleotide insertion with 6-fold lower efficiency opposite a template A and 19-27-fold lower efficiency opposite a template T or C. Furthermore, dCMP insertion was greatly preferred regardless of the specific template base. Human REV1 inserted a dCMP efficiently opposite a template 8-oxoguanine, (+)-trans-anti-benzo[a]pyrene-N2-dG, (-)-trans-anti-benzo[a]pyrene-N2-dG and 1,N6-ethenoadenine adducts, very inefficiently opposite an acetylaminofluorene-adducted guanine, but was unresponsive to a template TT dimer or TT (6-4) photoproduct. Surprisingly, the REV1 specificity of nucleotide insertion was very similar in response to different DNA lesions with greatly preferred C insertion and least frequent A insertion. By combining the dCMP insertion activity of human REV1 with the extension synthesis activity of human polymerase kappa, bypass of the trans-anti-benzo[a]pyrene-N2-dG adducts and the 1,N6-ethenoadenine lesion was achieved by the two-polymerase two-step mechanism. These results suggest that human REV1 is a specialized DNA polymerase that may contribute to dCMP insertion opposite many types of DNA damage during lesion bypass.
authors.affiliation: 306 Health Sciences Research Building, Graduate Center for Toxicology, University of Kentucky, Lexington, KY 40536, USA.
authors.forename: Yanbin
authors.initials: Y
authors.lastname: Zhang
authors.forename: Xiaohua
authors.initials: X
authors.lastname: Wu
authors.forename: Olga
authors.initials: O
authors.lastname: Rechkoblit
authors.forename: Nicholas E
authors.initials: NE
authors.lastname: Geacintov
authors.forename: John-Stephen
authors.initials: JS
authors.lastname: Taylor
authors.forename: Zhigang
authors.initials: Z
authors.lastname: Wang
mesh_terms: D001665:Binding Sites; D004247:DNA / Q000235:genetics / Q000378:metabolism; D004249:DNA Damage; D004259:DNA-Directed DNA Polymerase / Q000378:metabolism; D003843:Deoxycytidine Monophosphate / Q000235:genetics / Q000378:metabolism; D005092:Exonucleases / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D009687:Nuclear Proteins; D009711:Nucleotides / Q000235:genetics / Q000378:metabolism; D009713:Nucleotidyltransferases / Q000235:genetics / Q000378:metabolism*; D011740:Pyrimidine Dimers / Q000235:genetics / Q000378:metabolism; D013698:Templates, Genetic; D000099270:Y-Family DNA Polymerases
chemical_list: D004247:DNA; D004259:DNA-Directed DNA Polymerase; D003843:Deoxycytidine Monophosphate; D005092:Exonucleases; D009687:Nuclear Proteins; D009711:Nucleotides; D009713:Nucleotidyltransferases; D011740:Pyrimidine Dimers; C429004:REV1 protein, human; D000099270:Y-Family DNA Polymerases